↓ Skip to main content

Dove Medical Press

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration

Overview of attention for article published in Drug Design, Development and Therapy, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
70 Mendeley
Title
Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
Published in
Drug Design, Development and Therapy, June 2021
DOI 10.2147/dddt.s295223
Pubmed ID
Authors

Rehan M Hussain, Bilal A Shaukat, Lauren M Ciulla, Audina M Berrocal, Jayanth Sridhar

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Other 7 10%
Student > Ph. D. Student 7 10%
Student > Bachelor 7 10%
Student > Doctoral Student 4 6%
Unspecified 3 4%
Other 10 14%
Unknown 32 46%
Readers by discipline Count As %
Medicine and Dentistry 12 17%
Biochemistry, Genetics and Molecular Biology 6 9%
Unspecified 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Agricultural and Biological Sciences 2 3%
Other 9 13%
Unknown 35 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2023.
All research outputs
#2,149,383
of 25,392,582 outputs
Outputs from Drug Design, Development and Therapy
#104
of 2,269 outputs
Outputs of similar age
#54,287
of 459,810 outputs
Outputs of similar age from Drug Design, Development and Therapy
#5
of 64 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 459,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.